Neuroendocrine Tumor (NET) Treatment


Neuroendocrine Tumor (NET) Treatment

Penn Medicine offers one of the only dedicated neuroendocrine tumor (NET) programs in the country with the combined expertise to treat both gastroenteropancreatic neuroendocrine tumors (GEP-NETs) and pheochromocytomas and paragangliomas (PHEOs). In addition, Penn Medicine’s program is the first and only one of its kind in the region.

Following the diagnosis and staging of neuroendocrine tumors, cancer specialists at Penn’s Abramson Cancer Center develop a personalized treatment plan. Penn’s treatment options for neuroendocrine tumors include:

  • Surgery
    • Local and local-regional excision
    • Debulking surgery, including liver resection
    • Radiofrequency ablation
    • Liver transplantation
  • Chemotherapy and biologic therapies
    • Hormone therapy
      • Octreotide
      • Proton pump inhibitors (PPIs)
    • Liver-directed therapies
      • Ethanol injection
      • Chemoembolization of the hepatic artery
    • Chemotherapy
    • Targeted therapy
  • External-beam radiation therapy
  • Clinical trials
  • Other treatments
    • Integrative medicine and wellness
    • Palliative care
    • Penn Home Care and Hospice

Because navigating a cancer diagnosis and its treatment options can be difficult, patients who wish to connect with a cancer specialist at Penn Medicine can speak with a cancer nurse, who can assist in making an appointment with the right physician.

To connect with a cancer nurse at Penn Medicine, patients should call 800-789-PENN.